Functional characterization of the murine Tnk1 promoter

被引:5
|
作者
Hoare, Sarasija [1 ]
Hoare, Kishalay [1 ]
Reinhard, Mary K. [2 ]
Flagg, Tammy O. [1 ]
May, William Stratford, Jr. [1 ]
机构
[1] Univ Florida, Dept Internal Med, Shands Canc Ctr, Gainesville, FL 32610 USA
[2] Univ Florida, Dept Infect Dis & Pathol, Coll Vet Med, Gainesville, FL 32610 USA
关键词
TRANSCRIPTIONAL ACTIVATION; GENE-EXPRESSION; TYROSINE KINASE; BINDING PROTEIN; DNA-SEQUENCES; CELLS; TATA; CANCER; ROLES; AP-2;
D O I
10.1016/j.gene.2009.05.010
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Tnk1/Kos1 is a non-receptor protein tyrosine kinase found to be a tumor suppressor. It negatively regulates cell growth by indirectly suppressing Ras activity. We identified and characterized the critical cis-elements required for Tnk1/Kos1's promoter activity. Results indicate that the murine Tnk1 promoter lacks a conventional TATA, CAAT or initiator element (Inr) but contains multiple transcription start sites. Transcription is initiated by a TATA-like element composed of an AT rich sequence at - 30 (30 bp upstream) from the major transcription start site and an Inr-like element that overlaps the multiple start sites. Deletion analysis of the m-Tnk1 promoter reveals the presence of both positive (- 25 to - 151) and negative (- 151 to - 1201) regulatory regions. The three GC boxes which bind Sp1 and Sp3 with high affinity, an AP2 site (that overlaps with an AML1 site) and a MED1 site comprise the necessary cis-elements of the proximal promoter required for both constitutive and inducible Tnk1/Kos1 expression. Importantly, results reveal that cellular stress reverses the repression of Tnk1/Kos1 and induces its expression through increased high affinity interactions between nuclear proteins Sp1, Sp3, AP2 and MEDI for the m-Tnk1 promoter. These findings provide a mechanism by which the m-Tnk1 promoter can be dynamically regulated during normal growth. Published by Elsevier B.V.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 50 条
  • [1] Determining the biological function of TNK1
    Kohler, Emmalee
    Lopez-Palacios, Tania
    Chan, Tsz-Yin
    Egbert, Christina
    Truman, Jacob
    Ashworth, Spencer
    Vaughan, Alec
    Andersen, Joshua
    Madhusanka, D.
    CANCER RESEARCH, 2023, 83 (07)
  • [2] Regulation of the Nonreceptor Tyrosine Kinase Tnk1
    Ahmed, Sultan
    Miller, Todd
    PROTEIN SCIENCE, 2021, 30 : 105 - 106
  • [3] Characterization of the tyrosine kinase Tnk1 and its binding with phospholipase C-γ1
    Felschow, DM
    Civin, CI
    Hoehn, GT
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 273 (01) : 294 - 301
  • [4] Absence and/or functional loss of the tumor suppressor Tnk1 is associated with various human neoplasms
    Hoare, Kishalay
    Flagg, Tammy
    Zamora, Bernadetta M.
    Reinhard, Mary K.
    Hoare, Sarasija
    May, W. Stratford
    CANCER RESEARCH, 2012, 72
  • [5] TNK1 negatively regulates TBK1 at ubiquitin condensates
    Lopez-Palacios, Tania
    Egbert, Christina M.
    Chan, Tsz-Yin
    Ashworth, Spencer
    Vaughan, Alec
    Andersen, Joshua
    FASEB JOURNAL, 2022, 36
  • [6] A mechanism of regulation for the ubiquitin-sensing kinase TNK1
    Vaughan, Alec J.
    Egbert, Christina
    Chan, Yin
    Lopez, Tania
    Ashworth, Spencer
    McCormack, Katherine
    Andersen, Joshua
    FASEB JOURNAL, 2022, 36
  • [7] Identification of activated Tnk1 kinase in Hodgkin's lymphoma
    T-L Gu
    J Cherry
    M Tucker
    J Wu
    C Reeves
    R D Polakiewicz
    Leukemia, 2010, 24 : 861 - 865
  • [8] Identification of activated Tnk1 kinase in Hodgkin's lymphoma
    Gu, T-L
    Cherry, J.
    Tucker, M.
    Wu, J.
    Reeves, C.
    Polakiewicz, R. D.
    LEUKEMIA, 2010, 24 (04) : 861 - 865
  • [9] Transcriptional regulation of the tumor suppressor Tnk1/Kos1
    Hoare, Sarasija
    Hoare, Kishalay
    Reinhard, Mary
    May, W. Stratford
    CANCER RESEARCH, 2009, 69
  • [10] TP-5809, a novel TNK1 inhibitor, suppresses TNK1 dependent signaling and tumor growth in a preclinical model of Hodgkin's lymphoma.
    Forostyan, Tetyana V.
    Tyagi, Ethika
    Foulks, Jason M.
    Lalonde, Matthew
    Andersen, Joshua L.
    Siddiqui, Adam
    Whatcott, Clifford J.
    Bearss, David
    Warner, Steve
    CANCER RESEARCH, 2021, 81 (13)